As ENOUGH (formerly 3fBio) move mycoprotein production from their scale up facility in Glasgow to full scale production in the Netherlands, they wanted to design a suite of early diagnosis tests to determine when a batch of product is growing sub-optimally in the hope that issues can be mitigated and avoid reductions in the amount or quality of product.

Owners of food waste AD plants are looking for alternative ways to valorise waste that contains both plastic and biobased substances. Carbogenics wanted to investigate whether fermentation from screening waste was possible and test a scaled-up version of their process for making biomethane from waste using bacteria.

Using bacteria to clean waste water and recover metal ions.

Turning low value fish waste into high value molecules using biotechnology.

Improving the process for making sustainable meat alternatives at scale.

Trialling techniques to assess the chemical properties of chitosan extracted through a novel process.

IBioIC project funding enabled The Antibody Company to develop a novel test that has the potential to substantially reduce spoilage issues for microbrewers.

Feasibility study helped to support the finance and sign off a £2.2 million capital project, resulting in a new AD plant being in place, commissioned and operational by June 2022.

IBioIC funding enabled the development and testing of 3D printed bioreactors for the deep desulphurisation of fuel oils.

Celtic Renewables find a new source for bacteria to expand their culture collection.

New technology may help reduce carbon emissions for the agriculture and aquaculture industries.

Feasibility Funding helps Celtic Renewables de-risk avenue of investigation and acquire data for further research.

3F BIO delivered their 18-month Proof of Concept programme whilst commissioning their equipment and operating systems within RapidBio, our facility in Glasgow.